Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model

A series of triazine and pyrimidine based ROCK inhibitors is described. An initial binding mode was established based on a homology model and the proposed interactions are consistent with the observed SAR. Compounds from the series are potent in a cell migration assay and possess a favorable kinase...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 19; no. 21; pp. 6027 - 6031
Main Authors Ho, Koc-Kan, Beasley, James R., Belanger, Laura, Black, Darcey, Chan, Jui-Hsiang, Dunn, David, Hu, Bing, Klon, Anthony, Kultgen, Steven G., Ohlmeyer, Michael, Parlato, Susan M., Ray, Peter C., Pham, Quynhchi, Rong, Yajing, Roughton, Andrew L., Walker, Tiffany L., Wright, Jane, Xu, Kai, Xu, Yan, Zhang, Limei, Webb, Maria
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.11.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of triazine and pyrimidine based ROCK inhibitors is described. An initial binding mode was established based on a homology model and the proposed interactions are consistent with the observed SAR. Compounds from the series are potent in a cell migration assay and possess a favorable kinase selectivity. In vivo activity was demonstrated for compound 1A in a spontaneous hypertensive rat model. The profile of a series of triazine and pyrimidine based ROCK inhibitors is described. An initial binding mode was established based on a homology model and the proposed interactions are consistent with the observed SAR. Compounds from the series are potent in a cell migration assay and possess a favorable kinase selectivity. In vivo activity was demonstrated for compound 1A in a spontaneous hypertensive rat model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2009.09.046